Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Liabilities (2020 - 2023)

Historic Total Liabilities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $13.3 million.

  • Terns Pharmaceuticals' Total Liabilities rose 4914.53% to $13.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.3 million, marking a year-over-year increase of 4914.53%. This contributed to the annual value of $10.1 million for FY2022, which is 2981.85% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Total Liabilities stood at $13.3 million for Q3 2023, which was up 4914.53% from $15.5 million recorded in Q2 2023.
  • Terns Pharmaceuticals' 5-year Total Liabilities high stood at $119.8 million for Q3 2020, and its period low was $6.7 million during Q2 2021.
  • Over the past 4 years, Terns Pharmaceuticals' median Total Liabilities value was $10.1 million (recorded in 2022), while the average stood at $30.7 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Total Liabilities tumbled by 9389.19% in 2021, and later soared by 10338.83% in 2023.
  • Terns Pharmaceuticals' Total Liabilities (Quarter) stood at $23.7 million in 2020, then tumbled by 67.23% to $7.8 million in 2021, then increased by 29.82% to $10.1 million in 2022, then skyrocketed by 31.53% to $13.3 million in 2023.
  • Its Total Liabilities stands at $13.3 million for Q3 2023, versus $15.5 million for Q2 2023 and $13.6 million for Q1 2023.